Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Return on Sales (2016 - 2018)

Armata Pharmaceuticals' Return on Sales history spans 6 years, with the latest figure at 3.27% for Q4 2018.

  • For Q4 2018, Return on Sales fell 23943.0% year-over-year to 3.27%; the TTM value through Dec 2018 reached 15.49%, up 6546.0%, while the annual FY2024 figure was 9.55%, 3232.0% up from the prior year.
  • Return on Sales for Q4 2018 was 3.27% at Armata Pharmaceuticals, down from 9.03% in the prior quarter.
  • Across five years, Return on Sales topped out at 242.7% in Q4 2017 and bottomed at 230.75% in Q2 2017.
  • The 5-year median for Return on Sales is 35.0% (2018), against an average of 42.9%.
  • The largest annual shift saw Return on Sales tumbled -83412bps in 2014 before it skyrocketed 41079bps in 2017.
  • A 5-year view of Return on Sales shows it stood at 25.71% in 2014, then skyrocketed by 34bps to 16.98% in 2015, then crashed by -890bps to 168.09% in 2016, then skyrocketed by 244bps to 242.7% in 2017, then plummeted by -99bps to 3.27% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Return on Sales are 3.27% (Q4 2018), 9.03% (Q3 2018), and 35.0% (Q2 2018).